SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY

被引：4
|
作者：
Suzuki, Shigeru [1 ]
Kokumai, Takahide [1 ]
Furuya, Akiko [1 ]
Takahashi, Satoru [1 ]
机构：
[1] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan
来源：
DIABETES CARE | 2023年 / 46卷 / 03期
基金：
日本学术振兴会;
关键词：
HYPERGLYCEMIA; HNF1A-MODY;
D O I：
10.2337/dc22-1573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E74 / E75
页数：2
相关论文
共 50 条
  • [1] Diabetic ketoacidosis in a female patient with HNF4A-MODY
    Harms, Marlen
    Stegemann, Birgit
    Beier, Bernhard
    Muessig, Karsten
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (03) : 214 - 217
  • [2] Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
    Oosterom, Nicole
    den Braber, Niala
    Laverman, Gozewijn D.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2022, 2022
  • [3] Identification of HNF1A-MODY and HNF4A-MODY in Irish families: Phenotypic characteristics and therapeutic implications
    Kyithar, M. P.
    Bacon, S.
    Pannu, K. K.
    Rizvi, S. R.
    Colclough, K.
    Ellard, S.
    Byrne, M. M.
    DIABETES & METABOLISM, 2011, 37 (06) : 512 - 519
  • [4] Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY
    Broome, David T.
    Mehdi, Alina
    Chase, Colby
    de Freitas, Maria Foss
    Gregg, Brigid E.
    Oral, Elif A.
    Herman, William H.
    DIABETES CARE, 2024, 47 (09) : e65 - e66
  • [5] Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
    Karlsson, E.
    Shaat, N.
    Groop, L.
    DIABETIC MEDICINE, 2008, 25 (07) : 788 - 791
  • [6] An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY
    Spiro, Andrew J.
    Vu, Katherine N.
    Warnock, Alicia Lynn
    CASE REPORTS IN ENDOCRINOLOGY, 2018, 2018
  • [7] Molecular mechanism of HNF-1A-mediated HNF4A gene regulation and promoterdriven HNF4A-MODY diabetes
    Kind, Laura
    Molnes, Janne
    Tjora, Erling
    Raasakka, Arne
    Myllykoski, Matti
    Colclough, Kevin
    Saint-Martin, Cecile
    Adelfalk, Caroline
    Dusatkova, Petra
    Pruhova, Stepanka
    Valtonen-Andre, Camilla
    Bellanne-Chantelot, Christine
    Arnesen, Thomas
    Kursula, Petri
    Njolstad, Pal Rasmus
    JCI INSIGHT, 2024, 9 (11)
  • [8] Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study
    Locke, Jonathan M.
    Dusatkova, Petra
    Colclough, Kevin
    Hughes, Alice E.
    Dennis, John M.
    Shields, Beverley
    Flanagan, Sarah E.
    Shepherd, Maggie H.
    Dempster, Emma L.
    Hattersley, Andrew T.
    Weedon, Michael N.
    Pruhova, Stepanka
    Patel, Kashyap A.
    DIABETOLOGIA, 2022, 65 (01) : 246 - 249
  • [9] Clinical spectrum of HNF4A-MODY (MODY1): From neonatal hyperinsulinism to diabetes in adults
    Salamanca Fresno, Luis
    Itza Martin, Nerea
    Gomes Porras, Mariana
    Guerrero Fernandez, Julio
    Ramirez Fernandez, Joaquin
    Abad Lopez, Ainhoa
    Solis Lopez, Mariano
    Rodriguez Jimenez, Carmen
    Nattero Chavez, Maria Lia
    Alvarez Escola, Cristina
    Gonzalez Casado, Isabel
    Campos Barros, Angel
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 88 - 88
  • [10] Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study
    Jonathan M. Locke
    Petra Dusatkova
    Kevin Colclough
    Alice E. Hughes
    John M. Dennis
    Beverley Shields
    Sarah E. Flanagan
    Maggie H. Shepherd
    Emma L. Dempster
    Andrew T. Hattersley
    Michael N. Weedon
    Stepanka Pruhova
    Kashyap A. Patel
    Diabetologia, 2022, 65 : 246 - 249
12345